BAY 94-9343 developed by Bayer HealthCare

• A fully human HuCAL-based antibody drug conjugate to treat mesotheliomas and ovarian and pancreatic carcinomas
• Target: Mesothelin

Additional Information:

• Study information on ClinicalTrials.gov